Drug-labels.com

PHL-Venlafaxine XR: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
37.5 mg, 75 mg, 150 mg

Patient Medication Information: uses, side effects, how to take - PHL-Venlafaxine XR

ABOUT THIS MEDICATION

What the medication is used for:

phl-VENLAFAXINE XR has been prescribed to you by your doctor to relieve your symptoms of the following conditions:

  • Depression (feeling sad, a change in appetite or weight,

    difficulty concentrating or sleeping, feeling tired, headaches, unexplained aches and pain)

What it does:

phl-VENLAFAXINE XR belongs to a group of medicines called antidepressants. phl-VENLAFAXINE XR is thought to work by affecting two naturally occurring brain chemicals, serotonin and norepinephrine.

When it should not be used:

  • Do not use phl-VENLAFAXINE XR if you are allergic to it

    or to any of the components of its formulation (see list of components at the end of this section). Stop taking the drug and contact your doctor immediately if you experience an allergic reaction or any severe or unusual side effects.

  • Do not use phl-VENLAFAXINE XR if you are currently

    taking or have recently taken monoamine oxidase inhibitor antidepressants (e.g. phenelzine sulphate, moclobemide).

What the medicinal ingredient is:

Venlafaxine Hydrochloride.

What the nonmedicinal ingredients are:

Dibutyl Sebecate, Ethyl Cellulose, Povidone and Sugar Spheres. Also contains:

37.5 mg: gelatine, black iron oxide, red iron oxide, titanium

dioxide, yellow iron oxide.

75 mg: gelatine, red iron oxide, titanium dioxide, yellow iron

oxide.

150 mg: gelatine, red iron oxide, titanium dioxide, yellow iron

oxide.

What dosage forms it comes in:

Extended Release Capsules: 37.5 mg, 75 mg and 150 mg.

WARNINGS AND PRECAUTIONS

During treatment with these types of medication it is
important that you and your doctor have good ongoing
communication about how you are feeling.
phl-VENLAFAXINE XR is not for use in children under 18 years
of age.
New or Worsened Emotional or Behavioural Problems

Particularly in the first few weeks or when doses are adjusted, a small number of patients taking drugs of this type may feel worse instead of better. They may experience new or worsened feelings of agitation, hostility, anxiety, impulsivity or thoughts about suicide, self-harm or harm to others. Suicidal thoughts and actions can occur in any age group but may be more likely in patients 18 to 24 years old. Should this happen to you, or to those in your care, consult your doctor immediately. Close observation by a doctor is necessary in this situation. Do not discontinue your medication on your own.

You may be more likely to think like this if you have previously had thoughts about harming yourself.

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.

Taking phl-VENLAFAXINE XR may increase your risk of breaking a bone if you are elderly or have osteoporosis or have other major risk factors for breaking a bone. You should take extra care to avoid falls especially if you get dizzy or have low blood pressure.

Before taking phl-VENLAFAXINE XR tell your doctor or pharmacist:

  • if you have ever had any allergic reaction to medications, food, etc;
  • all your medical conditions, including a history of seizures, liver disease, kidney disease, heart problems or high cholesterol;
  • if you have a bleeding disorder or have been told that you have low platelets.
  • if you have blood pressure problems;
  • any medications (prescription or non-prescription) which you are taking, especially monoamine oxidase (MAO) inhibitors (e.g. phenelzine sulfate, tranylcypromine sulfate, moclobemide or selegeline) or any other antidepressants, weight-loss medication, sleeping pills, antianxiety drugs, or medication to control blood pressure;
  • if you are pregnant or thinking about becoming pregnant, or if you are breast feeding;
  • your habits of alcohol and/or street drug consumption;
  • any natural or herbal products you are taking (e.g., St. John’s

Wort).

  • if you had a recent bone fracture or were told you have

    osteoporosis or risk factors for osteoporosis.

  • if you drive a vehicle or perform hazardous tasks during your

    work.

  • if you have glaucoma or increased pressure in your eyes.

Discontinuing phl-VENLAFAXINE XR

It is very important that you do NOT stop taking these medications without first consulting your doctor. See SIDE EFFECTS AND WHAT TO DO ABOUT THEM section for more information.

Effects on Pregnancy and Newborns

Post-marketing reports indicate that some newborns whose mothers took an SSRI (selective serotonin reuptake inhibitor) or other newer anti-depressants, such as venlafaxine hydrochloride extended release Capsules, during pregnancy have developed complications at birth requiring prolonged hospitalization, breathing support and tube feeding. Reported symptoms included feeding and/or breathing difficulties, seizures, tense or overly relaxed muscles, jitteriness and constant crying.

In most cases, the SSRI or other newer anti-depressant was taken during the third trimester of pregnancy. These symptoms are consistent with either a direct adverse effect of the antidepressant on the baby, or possibly a discontinuation syndrome caused by sudden withdrawal from the drug. These symptoms normally resolve over time. However, if your baby experiences any of these symptoms, contact your doctor as soon as you can.

If you are pregnant and taking an SSRI, or other newer anti-depressant, you should discuss the risks and benefits of the various treatment options with your doctor. It is very important that you do NOT stop taking these medications without first consulting your doctor. See SIDE EFFECTS AND WHAT TO DO ABOUT THEM section for more information.

INTERACTIONS WITH THIS MEDICATION

Do not use phl-VENLAFAXINE XR if you are taking or have
recently taken monoamine oxidase inhibitors.
You should avoid taking St. John’s Wort if you are taking
phl-VENLAFAXINE XR.

Certain laboratory results may be affected by use of phl-VENLAFAXINE XR, discuss with your doctor if you receive any unusual lab reports.

You should tell your doctor if you are taking or have recently
taken any medications (prescription, non-prescription or
natural/herbal), especially:
  • other antidepressants, such as SSRIs and certain tricyclics
  • other drugs that affect serotonin such as, lithium, linezolid,
sibutramine, tryptophan, triptans used to treat migraines
  • certain medicines used to treat pain, such as fentanyl (used in
anaesthesia or to treat chronic paint), tramadol, tapentadol,
meperidine, methadone, pentazocine
  • certain medicines used to treat cough, such as dextromethorphan
  • certain medicines used to treat schizophrenia
  • certain medicines used to treat bipolar depression, such as lithium
  • metoprolol or other medications used to treat high blood pressure and angina
  • certain medicines which may affect blood clotting and increase bleeding, such as oral anti-coagulants (e.g. warfarin, dabigatran) acetylsalicylic acid and other non-steroidal anti-inflammatory drugs (e.g. ibuprofen)
  • certain medicines used to treat epilepsy
  • cimetidine
  • In general, drinking alcoholic beverages should be kept to a minimum or avoided completely while taking phl-VENLAFAXINE XR.
  • Ketoconazole

PROPER USE OF THIS MEDICATION

Usual dose:

  • It is very important that you take phl-VENLAFAXINE XR exactly as your doctor has instructed.
  • Never increase or decrease the amount of phl-

    VENLAFAXINE XR you, or those in your care if you are a caregiver or guardian, are taking unless your doctor tells you to and do not stop taking this medication without consulting your doctor.

  • As with all antidepressants improvement with phl-

    VENLAFAXINE XR is gradual. You may not have noticeable effect in the first few days of treatment. Some symptoms may begin to improve within about 2 weeks but significant improvement can take several weeks.

  • phl-VENLAFAXINE XR should be taken once a day with food, as prescribed; do not divide, crush or chew the capsules.

REMEMBER: This medicine has been prescribed only for you. Do not give it to anybody else. If you have any further questions, please ask your doctor or pharmacist.

Overdose:

Missed Dose:

If you happen to miss a dose, do not try to make up for it by doubling up on the dose next time. Just take your next regularly scheduled dose and try not to miss any more.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medications, phl-VENLAFAXINE XR can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Some of these side effects may In case of overdose, contact your doctor, the nearest hospital emergency department or your local poison control centre, even though you may not feel sick.

be dose related. Consult your doctor if you experience these or other side effects, as the dose may have to be adjusted.

If you experience an allergic reaction (including red skin, hives, itching, swelling of the lips, face, tongue, throat, trouble breathing, wheezing, shortness of breath, skin rashes, blisters of the skin, sores or pain in the mouth or eyes) or any severe or unusual side effects, stop taking the drug and contact your doctor immediately.

Some side effects of phl-VENLAFAXINE XR are:

  • headache
  • nausea
  • dry mouth
  • constipation
  • loss of appetite
  • vomiting
  • sleepiness
  • dizziness
  • insomnia
  • sexual problems
  • weakness
  • sweating
  • nervousness
  • abnormal vision
  • abnormal dreams

Particularly in the first few weeks or when doses are adjusted, a small number of patients taking drugs of this type may feel worse instead of better; for example, they may experience unusual feelings of agitation, hostility or anxiety, or have impulsive or disturbing thoughts such as thoughts of self-harm or harm to others. Should this happen to you, or to those in your care if you are a caregiver or guardian, consult your doctor immediately; do not discontinue your medication on your own.

phl-VENLAFAXINE XR does not usually affect people’s normal activities. However, some people feel sleepy while taking it, in which case they should not drive or operate machinery.

Although psychiatric disorders may be associated with decreases in sexual desire, performance and satisfaction, treatment with this medication may also affect sexual functioning.

phl-VENLAFAXINE XR may increase blood pressure in some people. You should have your blood pressure measured prior to starting phl-VENLAFAXINE XR and during treatment. High blood pressure should be controlled before starting phl-VENLAFAXINE XR. Blood pressure changes may sometimes be sudden and without warning. Consult your doctor if you have symptoms that may indicate a sudden rise in your blood pressure, such as headache (particularly in the back of head/neck when waking up); stronger, possibly more rapid, or irregular heart beat; chest pain; dizziness; excessive tiredness; or blurred vision.

phl-VENLAFAXINE XR may raise cholesterol levels in some patients. Blood cholesterol tests may be required by your doctor during treatment with phl-VENLAFAXINE XR.

Discontinuation Symptoms
Contact your doctor before stopping or reducing your dosage of
phl-VENLAFAXINE XR. Symptoms such as anorexia (loss of
appetite, loss of weight), anxiety, agitation (restlessness),
aggression, confusion, convulsions, coordination problems,
diarrhea, dizziness, dry mouth, fatigue, headache, hypomania
(rapid mood swings), insomnia, nausea, nervousness, nightmares,
paresthesia (sensation of tingling, burning or crawling of the
skin), electric shock sensations, sleep disturbances, somnolence
(drowsiness), sweating, tinnitus (ringing in the ears), vertigo
(sensation that the world is spinning), vomiting and other
symptoms have been reported after stopping treatment, reducing
the dosage of phl-VENLAFAXINE XR, or when a dose is
missed. These symptoms usually disappear without needing
treatment. Tell your doctor immediately if you have these or any
other symptoms. Your doctor may adjust the dosage of phl-
VENLAFAXINE XR to alleviate the symptoms.
Effects on Newborns
Some newborns whose mothers took an SSRI (Selective
Serotonin Reuptake Inhibitor) or other newer anti-depressant,
such as phl-VENLAFAXINE XR, during pregnancy have shown
such symptoms as breathing and feeding difficulties, jitteriness
and constant crying. If your baby experiences any of these
symptoms, contact your doctor as soon as you can. See
WARNINGS AND PRECAUTIONS section for more
information.
SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk with your doctor or pharmacist right awayStop taking drug and seek immediat e emergenc y medical attention
Only if severeIn all cases
CommonIncreased blood pressure that persists [see also Severe Hypertension below]
CommonFast heartbeat
UncommonAllergic reactions [red skin, hives, itching, swelling of the lips, face, tongue, throat, trouble breathing, wheezing, shortness of breath, skin rashes, blisters of the skin, sores or pain in the mouth or eyes]
UncommonLow sodium level in blood [symptoms of tiredness, weakness, confusion combined with achy, stiff or uncoordinated muscles]
Unknown

Low Platelets:

Bruising or unusual bleeding from the skin or other areas

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effect

Talk with your

doctor or pharmacist right

away

Stop

taking drug and seek

immediat

e

emergenc y medical attention

Only if severeIn all cases
Uncommon

Mania/hypomania [elevated or irritable mood, decreased need for sleep, racing

thoughts]

UncommonAkathisia [feeling restless and unable to sit or stand still]
UncommonHallucinations [strange visions or sounds]
UncommonUncontrollable movements of the body or face
UncommonInability to urinate
Uncommon

Gastrointestinal

bleeding [vomiting blood or passing blood in stools]

Rare

Seizures [loss of

consciousness with uncontrollable shaking “fit”]

Rare

Serotonin syndrome [a combination of most or all of the following; confusion,

restlessness, sweating, shaking, shivering, high fever, sudden jerking of the muscles, hallucinations, fast heartbeat]

Rare

Liver disorder

[symptoms include nausea, vomiting, loss of appetite combined with itching,

yellowing of the skin or eyes, dark urine]

RareGlaucoma: Increased pressure in the eyes eye pain and blurred vision

See Warnings and

Precautions

New or worsened emotional or

behavioural problems

See Side

Effects and What to Do About Them

Severe Hypertension [symptoms include headache, stronger and possibly faster heartbeat, chest pain, dizziness, excessive tiredness, blurred vision]

This is not a complete list of side effects. For any unexpected effects while taking phl-VENLAFAXINE XR, contact your doctor or pharmacist.

HOW TO STORE IT

  • Store phl-VENLAFAXINE XR between 15°C and 30°C,
in a dry place.
  • Keep container tightly closed.
  • Keep all medicines out of the sight and reach of children.
  • If your doctor tells you to stop taking phl-
VENLAFAXINE XR please return any left over
medicine to your pharmacist.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program

      Health Canada

      Postal Locator 0701E Ottawa, ON K1A 0K9 Postage paid labels, Canada Vigilance Reporting Form and the adverse reactions reporting guidelines are available on the MedEffectTM Canada Website at

www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor, Pharmel Inc, at: 1-888-550-6060

Pharmel Inc.

Montreal Quebec

H4P 2T4

Last revised: February 28, 2013

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02299321

Revision date stated in the text: February 28, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PHL-Venlafaxine XR

Rx or OTC
Prescription (Rx)?
DIN 02299321, 02299348, 02299356
Schedule(s) PRESCRIPTION
Active ingredient(s) Venlafaxine (venlafaxine hydrochloride)
Dosage form(s) Capsule (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06A Antidepressants
        1. N06AX Other antidepressants
          1. N06AX16 Venlafaxine
Company PHARMEL INC
Current status Cancelled Pre Market
Current status date September 13, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02299321 37.5 MG Capsule (Extended-Release) Cancelled Pre Market September 13, 2017
02299348 75 MG Capsule (Extended-Release) Cancelled Pre Market September 13, 2017
02299356 150 MG Capsule (Extended-Release) Cancelled Pre Market September 13, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.